Literature DB >> 33556624

Aberrant gene expression induced by a high fat diet is linked to H3K9 acetylation in the promoter-proximal region.

Núria Morral1, Sheng Liu2, Abass M Conteh3, Xiaona Chu2, Yue Wang2, X Charlie Dong3, Yunlong Liu4, Amelia K Linnemann5, Jun Wan4.   

Abstract

Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease, with an estimated global prevalence of 1 in 4 individuals. Aberrant transcriptional control of gene expression is central to the pathophysiology of metabolic diseases. However, the molecular mechanisms leading to gene dysregulation are not well understood. Histone modifications play important roles in the control of transcription. Acetylation of histone 3 at lysine 9 (H3K9ac) is associated with transcriptional activity and is implicated in transcript elongation by controlling RNA polymerase II (RNAPII) pause-release. Hence, changes in this histone modification may shed information on novel pathways linking transcription control and metabolic dysfunction. Here, we carried out genome-wide analysis of H3K9ac in the liver of mice fed a control or a high-fat diet (an animal model of NAFLD), and asked whether this histone mark associates with changes in gene expression. We found that over 70% of RNAPII peaks in promoter-proximal regions overlapped with H3K9ac, consistent with a role of H3K9ac in the regulation of transcription. When comparing high-fat with control diet, approximately 17% of the differentially expressed genes were associated with changes in H3K9ac in their promoters, showing a strong correlation between changes in H3K9ac signal and gene expression. Overall, our data indicate that in response to a high-fat diet, dysregulated gene expression of a subset of genes may be attributable to changes in transcription elongation driven by H3K9ac. Our results point at an added mechanism of gene regulation that may be important in the development of metabolic diseases.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Gene regulation; High-fat diet; Histone acetylation; Liver; Non-alcoholic fatty liver disease

Mesh:

Substances:

Year:  2021        PMID: 33556624      PMCID: PMC7933127          DOI: 10.1016/j.bbagrm.2021.194691

Source DB:  PubMed          Journal:  Biochim Biophys Acta Gene Regul Mech        ISSN: 1874-9399            Impact factor:   4.490


  75 in total

1.  Genomic maps and comparative analysis of histone modifications in human and mouse.

Authors:  Bradley E Bernstein; Michael Kamal; Kerstin Lindblad-Toh; Stefan Bekiranov; Dione K Bailey; Dana J Huebert; Scott McMahon; Elinor K Karlsson; Edward J Kulbokas; Thomas R Gingeras; Stuart L Schreiber; Eric S Lander
Journal:  Cell       Date:  2005-01-28       Impact factor: 41.582

2.  NGSUtils: a software suite for analyzing and manipulating next-generation sequencing datasets.

Authors:  Marcus R Breese; Yunlong Liu
Journal:  Bioinformatics       Date:  2013-01-12       Impact factor: 6.937

3.  Hepatic gene expression in patients with obesity-related non-alcoholic steatohepatitis.

Authors:  Zobair M Younossi; Francesco Gorreta; Janus P Ong; Karen Schlauch; Luca Del Giacco; Hazem Elariny; Amy Van Meter; Abraham Younoszai; Zachary Goodman; Anna Baranova; Alan Christensen; Geraldine Grant; Vikas Chandhoke
Journal:  Liver Int       Date:  2005-08       Impact factor: 5.828

4.  Regulation of steatohepatitis and PPARγ signaling by distinct AP-1 dimers.

Authors:  Sebastian C Hasenfuss; Latifa Bakiri; Martin K Thomsen; Evan G Williams; Johan Auwerx; Erwin F Wagner
Journal:  Cell Metab       Date:  2014-01-07       Impact factor: 27.287

5.  Evidence for the role of oxidative stress in the acetylation of histone H3 by ethanol in rat hepatocytes.

Authors:  Mahua Choudhury; Pil-Hoon Park; Daniel Jackson; Shivendra D Shukla
Journal:  Alcohol       Date:  2010-08-12       Impact factor: 2.405

6.  Acetyl-CoA induces cell growth and proliferation by promoting the acetylation of histones at growth genes.

Authors:  Ling Cai; Benjamin M Sutter; Bing Li; Benjamin P Tu
Journal:  Mol Cell       Date:  2011-05-20       Impact factor: 17.970

Review 7.  The emerging role of nuclear receptor RORalpha and its crosstalk with LXR in xeno- and endobiotic gene regulation.

Authors:  Taira Wada; Hong Soon Kang; Anton M Jetten; Wen Xie
Journal:  Exp Biol Med (Maywood)       Date:  2008-06-05

8.  Identification of oxysterol 7alpha-hydroxylase (Cyp7b1) as a novel retinoid-related orphan receptor alpha (RORalpha) (NR1F1) target gene and a functional cross-talk between RORalpha and liver X receptor (NR1H3).

Authors:  Taira Wada; Hong Soon Kang; Martin Angers; Haibiao Gong; Shikha Bhatia; Shaheen Khadem; Songrong Ren; Ewa Ellis; Stephen C Strom; Anton M Jetten; Wen Xie
Journal:  Mol Pharmacol       Date:  2007-11-30       Impact factor: 4.436

9.  Prediction of RNA Polymerase II recruitment, elongation and stalling from histone modification data.

Authors:  Yun Chen; Mette Jørgensen; Raivo Kolde; Xiaobei Zhao; Brian Parker; Eivind Valen; Jiayu Wen; Albin Sandelin
Journal:  BMC Genomics       Date:  2011-11-03       Impact factor: 3.969

10.  Sexually dimorphic genome-wide binding of retinoid X receptor alpha (RXRα) determines male-female differences in the expression of hepatic lipid processing genes in mice.

Authors:  Astrid Kosters; Deqiang Sun; Hao Wu; Feng Tian; Julio C Felix; Wei Li; Saul J Karpen
Journal:  PLoS One       Date:  2013-08-19       Impact factor: 3.240

View more
  2 in total

1.  Acetyl-CoA metabolism drives epigenome change and contributes to carcinogenesis risk in fatty liver disease.

Authors:  Gabriella Assante; Sriram Chandrasekaran; Stanley Ng; Aikaterini Tourna; Carolina H Chung; Kowsar A Isse; Jasmine L Banks; Ugo Soffientini; Celine Filippi; Anil Dhawan; Mo Liu; Steven G Rozen; Matthew Hoare; Peter Campbell; J William O Ballard; Nigel Turner; Margaret J Morris; Shilpa Chokshi; Neil A Youngson
Journal:  Genome Med       Date:  2022-06-23       Impact factor: 15.266

2.  Insights from a high-fat diet fed mouse model with a humanized liver.

Authors:  Romil Saxena; Mehdi Nassiri; Xiao-Ming Yin; Núria Morral
Journal:  PLoS One       Date:  2022-05-09       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.